Head and Neck Cancer PDX Models

Head & Neck Cancer Preclinical Solutions

Online Inquiry

Name *

Email *

Phone *

Services Interested *

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

In advancing head and neck cancer PDX models, our expertise at Alfa Cytology is crucial for improving therapeutic outcomes. We employ advanced methodologies and a dedicated team to develop reliable PDX models that effectively mimic patient tumors while ensuring safety. Our professionals, with extensive backgrounds in oncology and model development, are committed to providing tailored solutions that enhance your research and treatment strategies.

Introduction to PDX Models

Patient-Derived Xenograft (PDX) models are powerful preclinical tools that involve the transplantation of patient tumor tissues into immunocompromised mice. These models retain the original tumor's histological characteristics, molecular heterogeneity, and drug response profiles, making them invaluable for cancer research, particularly in head and neck cancers. PDX models facilitate the exploration of tumor biology, evaluation of therapeutic efficacy, and discovery of biomarkers, offering a realistic platform for personalized medicine. By bridging the gap between laboratory findings and clinical applications, PDX models play a vital role in advancing cancer treatment strategies.

Fig. 1 Tumor cell resource, establishment, and application of PDX models.(Gu A, et al., 2025)

Applications of PDX Models

Drug Screening and Development: PDX models are utilized to evaluate the efficacy of chemotherapy, targeted therapies, and immunotherapies, helping researchers identify effective treatments for specific tumors.
Biomarker Discovery: These models aid in discovering molecular biomarkers that predict treatment responses, allowing for personalized therapy approaches based on tumor mutations and expression profiles.
Tumor Heterogeneity Studies: PDX models enable the exploration of intratumoral heterogeneity and the tumor microenvironment, providing insights into cancer stem cells and resistance mechanisms.
Personalized Medicine: By serving as "avatar" models that closely resemble patient tumors, PDX models facilitate tailored treatment strategies, enhancing clinical decision-making.
Radiotherapy Research: PDX models are used to assess tumor sensitivity to radiation therapy and investigate combination treatment strategies to boost therapeutic efficacy.

Our Services

At Alfa Cytology, we provide specialized development services for head and neck cancer PDX models, leveraging our extensive expertise and innovative research. Our customized solutions directly tackle the unique challenges within this domain, ensuring the success of your preclinical projects.

Custom PDX Model Development

Tailored creation of PDX models using fresh tumor specimens to meet your specific research needs.

Drug Efficacy Testing

Evaluation of tumor responses to various therapies, including chemotherapy and immunotherapies, providing essential data for preclinical studies.

Biomarker Discovery

Assistance in identifying predictive biomarkers to guide personalized treatment strategies.

Comprehensive Tumor Characterization

Molecular and histological profiling of PDX models to enhance the accuracy of research insights.

Alfa Cytology is dedicated to providing a comprehensive platform for head and neck cancer PDX model development. We understand the importance of timely research, and that's why we integrate advanced experimental techniques with our expert scientific team to ensure your projects progress smoothly. Contact us today to learn more about our tailored PDX model services and how we can accelerate the advancement of your research initiatives.

Reference

Gu A, et al. Patient-derived xenograft model in cancer: establishment and applications. MedComm (2020). 2025 Jan 19;6(2):e70059.

For research use only.